Adult Vaccines 2024
Closed Solicitation Posted
- Solicitation number
- 75D301-24-R-72943
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) is seeking to award one or more indefinite-delivery, indefinite-quantity (ID/IQ) contracts for the purchase of various adult vaccines. The required vaccine types include Hepatitis A, Hepatitis B, Hepatitis A&B combination, Herpes Zoster, Human Papillomavirus (HPV9), E-IPV, Measles/Mumps/Rubella, Meningococcal, Mpox, Pneumococcal, Tetanus/Diphtheria, and Varicella. Key requirements include a minimum 12-month shelf life and specified federal excise tax amounts per dose. Offerors must be manufacturers of the required vaccines and submit proposals by April 5, 2024. The contract period of performance is from July 1, 2024 to June 30, 2025, with vaccines ordered via the CDC's Vaccine Tracking System (VTrckS) using a fair opportunity process.
This opportunity is not set-aside and the applicable NAICS code is 325412 - Pharmaceutical Preparation Manufacturing. The RFP does not identify any potential incumbent contractors. The solicitation outlines estimated maximum and minimum quantities for each vaccine type, but does not provide an overall contract value or budget range. The place of performance is the United States.
Notice text
2 versions
Update #2 · Latest ·
UPDATE 3/29/2024: The answers to vendor questions have been uploaded to this posting.
The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) requires the award of one or more indefinite-delivery, indefinite-quantity contracts for the purchase of the following adult vaccines, at the estimated quantities listed, manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration. See attached RFP for details.
Hepatitis A Adult Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $0.75 per dose
Maximum: 1,000,000 doses
Minimum: 100 doses
Hepatitis B Adult Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $0.75 per dose
Maximum: 750,000 doses
Minimum: 100 doses
Hepatitis A & B Combination Adult Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $1.50 per dose
Maximum: 250,000 doses
Minimum: 100 doses
Herpes Zoster Adult Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax N/A
Maximum: 500,000 doses
Minimum: 100 doses
Human Papillomavirus (HPV9) Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $0.75 per dose
Maximum: 300,000 doses
Minimum: 100 doses
E-IPV Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $0.75 per dose
Maximum: 500,000 doses
Minimum: 100 doses
Measles, Mumps, and Rubella Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $2.25 per dose
Maximum: 250,000 doses
Minimum: 100 doses
Meningococcal Conjugate-Serogroup B Meningococcal Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $1.50 per dose
Maximum: 200,000 doses
Minimum: 100 doses
Mpox Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax TBD
Maximum: 500,000 doses
Minimum: 100 doses
Serogroup B Meningococcal Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $0.75 per dose
Maximum: 200,000 doses
Minimum: 100 doses
Meningococcal Conjugate (Groups A, C, Y & W) Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $0.75 per dose
Maximum: 200,000 doses
Minimum: 100 doses
Pneumococcal Conjugate (PCV) Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $0.75 per dose
Maximum: 500,000 doses
Minimum: 100 doses
Pneumococcal Polysaccharide Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax N/A
Maximum: 500,000 doses
Minimum: 100 doses
Tetanus and Diptheria Toxoids Vaccine for Adults:
Min. Shelf Life 12 months
Fed. Excise Tax $1.50 per dose
Maximum: 100,000 doses
Minimum: 100 doses
Tetanus, Reduced Diptheria Toxoid & Acellular Pertusis (TdaP) Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $2.25 per dose
Maximum: 850,000 doses
Minimum: 100 doses
Varicella Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $0.75 per dose
Maximum: 150,000 doses
Minimum: 10 doses
Update #1 ·
The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) requires the award of one or more indefinite-delivery, indefinite-quantity contracts for the purchase of the following adult vaccines, at the estimated quantities listed, manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration. See attached RFP for details.
Hepatitis A Adult Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $0.75 per dose
Maximum: 1,000,000 doses
Minimum: 100 doses
Hepatitis B Adult Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $0.75 per dose
Maximum: 750,000 doses
Minimum: 100 doses
Hepatitis A & B Combination Adult Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $1.50 per dose
Maximum: 250,000 doses
Minimum: 100 doses
Herpes Zoster Adult Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax N/A
Maximum: 500,000 doses
Minimum: 100 doses
Human Papillomavirus (HPV9) Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $0.75 per dose
Maximum: 300,000 doses
Minimum: 100 doses
E-IPV Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $0.75 per dose
Maximum: 500,000 doses
Minimum: 100 doses
Measles, Mumps, and Rubella Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $2.25 per dose
Maximum: 250,000 doses
Minimum: 100 doses
Meningococcal Conjugate-Serogroup B Meningococcal Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $1.50 per dose
Maximum: 200,000 doses
Minimum: 100 doses
Mpox Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax TBD
Maximum: 500,000 doses
Minimum: 100 doses
Serogroup B Meningococcal Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $0.75 per dose
Maximum: 200,000 doses
Minimum: 100 doses
Meningococcal Conjugate (Groups A, C, Y & W) Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $0.75 per dose
Maximum: 200,000 doses
Minimum: 100 doses
Pneumococcal Conjugate (PCV) Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $0.75 per dose
Maximum: 500,000 doses
Minimum: 100 doses
Pneumococcal Polysaccharide Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax N/A
Maximum: 500,000 doses
Minimum: 100 doses
Tetanus and Diptheria Toxoids Vaccine for Adults:
Min. Shelf Life 12 months
Fed. Excise Tax $1.50 per dose
Maximum: 100,000 doses
Minimum: 100 doses
Tetanus, Reduced Diptheria Toxoid & Acellular Pertusis (TdaP) Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $2.25 per dose
Maximum: 850,000 doses
Minimum: 100 doses
Varicella Vaccine:
Min. Shelf Life 12 months
Fed. Excise Tax $0.75 per dose
Maximum: 150,000 doses
Minimum: 10 doses
Files
| File | Type | Posted |
|---|---|---|
| Questions and Answers RFP 75D301-24-R-72943.xlsx | XLSX spreadsheet | |
| A19. RFP 75D301-24-R-72943.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response | Office of the Assistant Secretary for Preparedness and Response | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity